Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 10, Pages 2903
Publisher
MDPI AG
Online
2020-10-16
DOI
10.3390/cancers12102903
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular characteristics of testicular germ cell tumors: pathogenesis and mechanisms of therapy resistance
- (2020) Khaleel I. Al-Obaidy et al. Expert Review of Anticancer Therapy
- CDK4/6 inhibition presents as a therapeutic option for paediatric and adult germ cell tumours and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanisms
- (2020) Margaretha A. Skowron et al. BRITISH JOURNAL OF CANCER
- Genomic landscape of platinum resistant and sensitive testicular cancers
- (2020) Chey Loveday et al. Nature Communications
- Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2
- (2020) Namrata Bora-Singhal et al. Scientific Reports
- Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
- (2020) Filipa Moreira-Silva et al. Pharmaceutics
- Epigenetic alterations as therapeutic targets in Testicular Germ Cell Tumours : current and future application of ‘epidrugs’
- (2020) Ana Rita Cardoso et al. Epigenetics
- Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
- (2019) João Lobo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epigenetic treatment combinations to effectively target cisplatin‐resistant germ cell tumors‐past, present, and future considerations
- (2019) C. Oing et al. Andrology
- m6A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance
- (2019) João Lobo et al. Journal of Translational Medicine
- Phase II study of avelumab in multiple relapsed/refractory germ cell cancer
- (2019) M. Mego et al. INVESTIGATIONAL NEW DRUGS
- Epigenetic Remodeling through Downregulation of Polycomb Repressive Complex 2 Mediates Chemotherapy Resistance in Testicular Germ Cell Tumors
- (2019) Ratnakar Singh et al. Cancers
- Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors
- (2019) Violeta Bakardjieva-Mihaylova et al. Cancers
- Detailed Characterization of Immune Cell Infiltrate and Expression of Immune Checkpoint Molecules PD-L1/CTLA-4 and MMR Proteins in Testicular Germ Cell Tumors Disclose Novel Disease Biomarkers
- (2019) João Lobo et al. Cancers
- Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series
- (2019) Christoph Oing et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data
- (2019) João Lobo et al. Cells
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses
- (2018) Daniela Matei et al. CLINICAL CANCER RESEARCH
- Molecular mechanisms of resistance in testicular germ cell tumors – Clinical implications
- (2018) Katarina Kalavska et al. CURRENT CANCER DRUG TARGETS
- Therapeutic approaches for refractory germ cell cancer
- (2018) Christoph Oing et al. Expert Review of Anticancer Therapy
- Testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists
- (2018) João Lobo et al. HUMAN PATHOLOGY
- An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis
- (2018) Andrea Necchi et al. EUROPEAN UROLOGY
- Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group
- (2018) Martin Fenner et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors
- (2018) Silvia Schmidtova et al. Current Oncology Reports
- 5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells
- (2018) Christoph Oing et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors
- (2018) Daniel Nettersheim et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- DNA methylation profiling as a tool for testicular germ cell tumors subtyping
- (2018) Ana L Costa et al. Epigenomics
- Testicular cancer
- (2018) Liang Cheng et al. Nature Reviews Disease Primers
- Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
- (2018) Vera Miranda-Gonçalves et al. Frontiers in Genetics
- The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors
- (2018) João Lobo et al. Cancers
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The epigenetics of testicular germ cell tumors: looking for novel disease biomarkers
- (2017) Ana Laura Costa et al. Epigenomics
- Current Management of Refractory Germ Cell Tumors and Future Directions
- (2017) J. Clayton Allen et al. Current Oncology Reports
- The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas
- (2016) Daniel Nettersheim et al. BRITISH JOURNAL OF CANCER
- The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo
- (2016) Sina Jostes et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Platinum-refractory germ cell tumors: an update on current treatment options and developments
- (2016) Christoph Oing et al. WORLD JOURNAL OF UROLOGY
- A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment
- (2016) Daniel Nettersheim et al. Oncotarget
- Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine
- (2016) Costantine Albany et al. Oncotarget
- Romidepsin-associated cardiac toxicity and ECG changes: A case report and review of the literature
- (2016) Zachary T Rivers et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells
- (2015) TOMAS GROH et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Aza-deoxycytidine induces apoptosis or differentiation via DNMT3B and targets embryonal carcinoma cells but not their differentiated derivatives
- (2014) P Wongtrakoongate et al. BRITISH JOURNAL OF CANCER
- Role of SOX2 in the Etiology of Embryonal Carcinoma, Based on Analysis of the NCCIT and NT2 Cell Lines
- (2014) Ronak Eini et al. PLoS One
- Cisplatin resistance in germ cell tumours: models and mechanisms
- (2014) C. Jacobsen et al. Andrology
- Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4
- (2013) M. Gutekunst et al. CANCER RESEARCH
- MicroRNA-302a sensitizes testicular embryonal carcinoma cells to cisplatin-induced cell death
- (2013) Lin Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- LSD1 Regulates Pluripotency of Embryonic Stem/Carcinoma Cells through Histone Deacetylase 1-Mediated Deacetylation of Histone H4 at Lysine 16
- (2013) F. Yin et al. MOLECULAR AND CELLULAR BIOLOGY
- Transcription Factors Sp1 and p73 Control the Expression of the Proapoptotic Protein NOXA in the Response of Testicular Embryonal Carcinoma Cells to Cisplatin
- (2012) Lara Grande et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acute Hypersensitivity of Pluripotent Testicular Cancer-Derived Embryonal Carcinoma to Low-Dose 5-Aza Deoxycytidine Is Associated with Global DNA Damage-Associated p53 Activation, Anti-Pluripotency and DNA Demethylation
- (2012) Bijesh K. Biswal et al. PLoS One
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancer
- (2011) Victoria L. Luchenko et al. CELL CYCLE
- The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression
- (2011) Daniel Nettersheim et al. GENES CHROMOSOMES & CANCER
- Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes
- (2011) Ulrike Beyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
- (2009) N Steele et al. BRITISH JOURNAL OF CANCER
- High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
- (2009) M. J. Beyrouthy et al. CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started